A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trials. Coste A, Paccoud O, Danion F, Conrad A, et al. Antimicrob Agents Chemother 2026;70:e0152325.

Read + Share

Amedeo Smart

Independent Medical Education